Trial Profile
Clinical Trials Insight: 700051754
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2009
Price :
$35
*
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Almac Discovery
- 17 Dec 2009 New trial record
- 15 Dec 2009 This trial has been initiated according to an Almac Discovery media release.